EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies

Waqas A Malick, Ori Waksman, Ron Do, Wolfgang Koenig, Aruna D Pradhan, Erik S G Stroes, Robert S Rosenson

JACC · 2023-04 · 81 (16) · 1646-1658

DOI: 10.1016/j.jacc.2023.02.034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC, 2023-04. Verfasst von Waqas A Malick und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisCardiovascular DiseasesHumansClinical Trials as TopicLipoproteinsTriglycerides

Stichwörter der Autor:innen

ANGPTL3APOC3VLDLapolipoprotein-Bremnant cholesteroltriglycerides

Substanzen

LipoproteinsTriglycerides

Autor:innen und Institutionen

  • The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany; Institute of Epidemiology and Medical Biometr…
  • Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, VA Boston Medical Center, Boston, Massachusetts, USA.
  • Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: robert.rosenson@mssm.edu.

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NIA NIH HHS

Zitieren

APA

Malick, W. A., Waksman, O., Do, R., Koenig, W., Pradhan, A. D., Stroes, E. S. G., & Rosenson, R. S. (2023). Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies. JACC, 81(16), 1646-1658. https://doi.org/10.1016/j.jacc.2023.02.034

Vancouver

Malick WA, Waksman O, Do R, Koenig W, Pradhan AD, Stroes ESG, et al. Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies. JACC. 2023;81(16):1646-1658. doi:10.1016/j.jacc.2023.02.034

BibTeX
@article{Malick2023,
  author = {Malick, Waqas A and Waksman, Ori and Do, Ron and Koenig, Wolfgang and Pradhan, Aruna D and Stroes, Erik S G and Rosenson, Robert S},
  title = {Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies},
  journal = {JACC},
  year = {2023},
  volume = {81},
  number = {16},
  pages = {1646--1658},
  doi = {10.1016/j.jacc.2023.02.034}
}
Kostenlos starten →